Last updated: 26 June 2024 at 4:30pm EST

David Pyott Net Worth




The estimated Net Worth of David E I Pyott is at least $9.01 Million dollars as of 24 June 2024. Mr. Pyott owns over 32,450 units of Alnylam Pharmaceuticals Inc stock worth over $8,534,599 and over the last 21 years he sold ALNY stock worth over $0. In addition, he makes $470,707 as Independent Director at Alnylam Pharmaceuticals Inc.

Mr. Pyott ALNY stock SEC Form 4 insiders trading

David has made over 28 trades of the Alnylam Pharmaceuticals Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 32,450 units of ALNY stock worth $2,620,662 on 24 June 2024.

The largest trade he's ever made was exercising 32,450 units of Alnylam Pharmaceuticals Inc stock on 24 June 2024 worth over $2,620,662. On average, David trades about 1,283 units every 38 days since 2003. As of 24 June 2024 he still owns at least 32,586 units of Alnylam Pharmaceuticals Inc stock.

You can see the complete history of Mr. Pyott stock trades at the bottom of the page.





David Pyott biography

David E.I. Pyott is an Independent Director of the Alnylam Pharmaceuticals, Inc. Mr. Pyott served as the Chief Executive Officer of Allergan, Inc., a global specialty pharmaceutical and medical device company, from January 1998 to March 2015 and as the Chair of Allergan’s board of directors from March 2001 until March 2015. Prior to Allergan, Mr. Pyott served as the Head of the Novartis Nutrition Division and as a member of the Executive Committee of Switzerland-based Novartis AG. Mr. Pyott also serves as the lead independent director at Avery Dennison Corporation, a director of BioMarin Pharmaceutical Inc. and a member of the Supervisory Board of Royal Philips in the Netherlands. Mr. Pyott formerly served as a director of Edwards Lifesciences Corporation.

What is the salary of David Pyott?

As the Independent Director of Alnylam Pharmaceuticals Inc, the total compensation of David Pyott at Alnylam Pharmaceuticals Inc is $470,707. There are 17 executives at Alnylam Pharmaceuticals Inc getting paid more, with John Maraganore having the highest compensation of $7,317,860.



How old is David Pyott?

David Pyott is 67, he's been the Independent Director of Alnylam Pharmaceuticals Inc since 2015. There are 2 older and 17 younger executives at Alnylam Pharmaceuticals Inc. The oldest executive at Alnylam Pharmaceuticals Inc is Phillip Sharp, 75, who is the Independent Director.

What's David Pyott's mailing address?

David's mailing address filed with the SEC is 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142.

Insiders trading at Alnylam Pharmaceuticals Inc

Over the last 20 years, insiders at Alnylam Pharmaceuticals Inc have traded over $140,068,015 worth of Alnylam Pharmaceuticals Inc stock and bought 4,419,116 units worth $1,983,132,563 . The most active insiders traders include Sanofi, Christoph H Westphal, and Kevin P Starr. On average, Alnylam Pharmaceuticals Inc executives and independent directors trade stock every 23 days with the average trade being worth of $11,181,724. The most recent stock trade was executed by Yvonne Greenstreet on 20 August 2024, trading 15,000 units of ALNY stock currently worth $1,275,000.



What does Alnylam Pharmaceuticals Inc do?

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.



What does Alnylam Pharmaceuticals Inc's logo look like?

Alnylam Pharmaceuticals Inc logo

Complete history of Mr. Pyott stock trades at Alnylam Pharmaceuticals Inc, Biomarin Pharmaceutical, Avery Dennison, Edwards Lifesciences Corp, and Pliant Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
24 Jun 2024 David E I Pyott
Director
Option 32,450 $80.76 $2,620,662
24 Jun 2024
32,586
23 Feb 2023 David E I Pyott
Director
Option 136 $196.24 $26,689
23 Feb 2023
136
13 Oct 2016 David E I Pyott
Director
Buy 27,900 $37.00 $1,032,300
13 Oct 2016
27,900
13 Oct 2016 David E I Pyott
Director
Buy 27,900 $37.00 $1,032,300
13 Oct 2016
27,900
31 Aug 2020 David E I Pyott
Director
Buy 12,800 $78.26 $1,001,728
31 Aug 2020
30,740
23 Apr 2020 David E I Pyott
Director
Option 1,414 $107.56 $152,090
23 Apr 2020
18,684
3 Feb 2020 David E I Pyott
Director
Option 5,027 $38.18 $191,931
3 Feb 2020
22,297
1 May 2019 David E I Pyott
Director
Option 1,977 $109.63 $216,739
1 May 2019
17,270
27 Nov 2018 David E I Pyott
Director
Option 2,000 $20.64 $41,280
27 Nov 2018
17,293
1 May 2018 David E I Pyott
Director
Option 3,066 $104.80 $321,317
1 May 2018
15,293
28 Aug 2017 David E I Pyott
Director
Option 2,000 $52.12 $104,240
28 Aug 2017
18,005
1 May 2017 David E I Pyott
Director
Option 2,245 $83.42 $187,278
1 May 2017
16,303
8 Aug 2016 David E I Pyott
Director
Option 2,000 $67.80 $135,600
8 Aug 2016
16,058
8 Aug 2016 David E I Pyott
Director
Option 2,000 $67.80 $135,600
8 Aug 2016
16,058
29 Apr 2016 David E I Pyott
Director
Option 2,620 $72.82 $190,788
29 Apr 2016
14,058
2 Nov 2015 David E I Pyott
Director
Option 2,000 $59.47 $118,940
2 Nov 2015
13,438
1 May 2015 David E I Pyott
Director
Option 1,874 $55.84 $104,644
1 May 2015
11,438
26 Apr 2015 David E I Pyott
Director
Option 524 $51.77 $27,127
26 Apr 2015
9,564
1 May 2014 David E I Pyott
Director
Option 1,015 $48.50 $49,228
1 May 2014
9,040
26 Apr 2014 David E I Pyott
Director
Option 914 $48.75 $44,558
26 Apr 2014
8,025
26 Apr 2013 David E I Pyott
Director
Option 912 $41.52 $37,866
26 Apr 2013
7,111
22 Apr 2013 David E I Pyott
Director
Option 436 $40.85 $17,811
22 Apr 2013
6,199
26 Apr 2012 David E I Pyott
Director
Option 389 $32.36 $12,588
26 Apr 2012
5,763
20 Apr 2012 David E I Pyott
Director
Option 437 $31.33 $13,691
20 Apr 2012
5,374
22 Apr 2011 David E I Pyott
Director
Option 437 $41.73 $18,236
22 Apr 2011
4,937
1 May 2013 David E I Pyott
Director
Buy 3,000 $62.95 $188,850
1 May 2013
48,429
6 Aug 2012 David E I Pyott
Director
Option 6,798 $23.54 $160,025
6 Aug 2012
52,227
18 Jan 2012 David E I Pyott
Director
Option 20,000 $12.89 $257,800
18 Jan 2012
63,068


Alnylam Pharmaceuticals Inc executives and stock owners

Alnylam Pharmaceuticals Inc executives and other stock owners filed with the SEC include: